The selection of commercially viable drug candidates and advancing their development
toward worldwide markets is a complex and challenging task that requires people with a broad
range of different qualifications and drug development know-how.

Luis Eduardo Caroli

CEO Director

Back to team

Caroli is a graduate in Dentistry from the Federal University of Rio de Janeiro and earned his degree in Law at University Cândido Mendes, along with four health-related specialties. He has worked in the business of searching, selecting and investing in innovative health care products and services since 2003. From 2003 to 2012, Luis headed an investment holding company in the health care segment and served as a Board member or Director of six companies. From 2004 to August 2012, he was a member of the Board of Directors of Pele Nova Biotecnologia SA, where he participated in the development of an asset from its discovery at the University of São Paulo-Ribeirão Preto through its successful market introduction in 2012. From 2009 to 2012, Luis served as CEO of Excellion Serviços Biomédicos S.A., a laboratory services company that supports applied cell therapy in the Brazilian market. Luis has been CEO and Director of Biozeus since the founding of the company in 2012.